Cutaneous Eruptions Associated With Androgen Receptor Inhibitors for Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials

被引：0
作者：
Ahmad, Ihtisham [1 ]
Sood, Siddhartha [1 ]
Al-Daqqaq, Zizo [1 ]
Bagit, Ahmed [1 ]
Maliyar, Khalad [2 ]
Mufti, Asfandyar [2 ,3 ]
Yeung, Jensen [2 ,3 ,4 ,5 ,6 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[4] Womens Coll Hosp, Dept Dermatol, Toronto, ON, Canada
[5] Prob Med Res, Waterloo, ON, Canada
[6] Womens Coll Hosp, Div Dermatol, 76 Grenville St,5th Floor, Toronto, ON M5S 1B2, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2024年 / 28卷 / 04期
关键词：
cutaneous eruption; meta-analysis; prostate cancer; androgen receptor inhibitor; adverse event; drug eruption;
D O I：
10.1177/12034754241239278
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：395 / 396
页数：2
相关论文
共 50 条
  • [31] Inhibition of VEGF agents therapy with or without docetaxel as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials
    Lei, Naijun
    Song, Zhengfang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S26 - S26
  • [32] Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
    Lallous, Nada
    Dalal, Kush
    Cherkasov, Artem
    Rennie, Paul S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06) : 12496 - 12519
  • [33] Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer Beyond the Androgen Receptor
    Loriot, Yohann
    Zoubeidi, Amina
    Gleave, Martin E.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 517 - +
  • [34] Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer
    Zhou, Tianyi
    Feng, Qin
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] Androgen receptor co-regulatory networks in castration-resistant prostate cancer
    Sung, Ying Ying
    Cheung, Edwin
    ENDOCRINE-RELATED CANCER, 2014, 21 (01) : R1 - R11
  • [36] Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
    Tsao, Che-Kai
    Galsky, Matthew D.
    Small, Alexander C.
    Yee, Tiffany
    Oh, William K.
    BJU INTERNATIONAL, 2012, 110 (11) : 1580 - 1588
  • [37] Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
    Miura, Noriyoshi
    Mori, Keiichiro
    Mostafaei, Hadi
    Quhal, Fahad
    Motlagh, Reza Sari
    Abufaraj, Mohammad
    Pradere, Benjamin
    Aydh, Abdulmajeed
    Laukhtina, Ekaterina
    D'Andrea, David
    Saika, Takashi
    Shariat, Shahrokh F.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (11) : 1881 - 1891
  • [38] Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
    Noriyoshi Miura
    Keiichiro Mori
    Hadi Mostafaei
    Fahad Quhal
    Reza Sari Motlagh
    Mohammad Abufaraj
    Benjamin Pradere
    Abdulmajeed Aydh
    Ekaterina Laukhtina
    David D’Andrea
    Takashi Saika
    Shahrokh F. Shariat
    International Journal of Clinical Oncology, 2020, 25 : 1881 - 1891
  • [39] Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials
    Wei-Xiang Qi
    Zan Shen
    Yang Yao
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1785 - 1790
  • [40] Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials
    Qi, Wei-Xiang
    Shen, Zan
    Yao, Yang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (12) : 1785 - 1790
12345